ReviewOncoTargets and therapy2016

Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer.

Katalin BoérPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.